BOSTON - Railing against a recent draft decision from CMS that would only allow Medicare coverage of brain amyloid imaging under narrowly defined circumstances, stakeholders from the Alzheimer’s community met in a special session at the Alzheimer’s Association International Conference July 15 to begin forging a unified response.
In its draft decision memo released July 3, CMS announced “the evidence is insufficient to conclude that the use of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?